• Français

Pharmacology Research Unit (PRU)

The mass spectrometry platform of the Pharmacology Research Unit (URP) is a new platform specialized in the monitoring assay of pharmaceutical molecules in different biological matrices that are part of the common scientific platforms of the CHU Sainte-Justine Research Center.

In January 2021, we launched an integrated pharmacology platform, supported in part by the CHU Sainte-Justine Research Center to assist researchers in pharmacokinetic studies involved in clinical trials or for small molecule assay in translational research projects.

We have dedicated expert staff and state-of-the-art equipment such as high-performance tandem mass spectrometers (LC-MS/MS), triple quad Agilent model 6410 and 64560, to assist your drug monitoring in a pediatric context of limited sampling volume.

We have extensive experience in dosing components (e.g., ruxolitinib, trametinib, imatinib, busulfan, cyclosporine, tacrolimus), for different parameters (Cmax, Cmin, free fraction) and vouch our full support in making this expertise available to the entire research community.

Equipments

  • 3 HPLC series 1260 Agilent
  • 2 Triple quad Agilent 6410 and 6460

Services

  • Development of methods for pharmacological assays in different biological matrices (e.g. plasma, breast milk)
  • Pharmacological assays using existing methods in the literature or in the clinical laboratory setting
  • Consulting service to initiate a project

Clientele

Academic, pharmaceutical or biotechnology industries interested in pharmacology.

Training

Upcoming – Extraction method

Financial partners

  • Grandir en santé Fund
  • Canada Foundation for Innovation (CFI)
  • CHU Sainte-Justine Foundation

Partner institutions

  • OPTILAB
  • CHU Sainte-Justine

Contact person

Audrey Denoncourt, LC-MS/MS specialist
​audrey.denoncourt.hsj@ssss.gouv.qc.ca

Others

Yves Théorêt
yves.theoret@umontreal.ca

Jean-Marie Leclerc
jean-marie.leclerc@umontreal.ca

Price List

Service*
Faisability Study Personalized prices for each project according to the number of molecules to be assayed, the complexity of the matrix, the number of samples, the duration of the project and the researcher's affiliation (internal, academic, private). 
Bioanalytical Method Development
Partial or Complete Validation of the Bioanalytical Method (Internal SOP or FDA)
Preparation and Extraction of the molecules to monitor in the samples (liquid-liquid or solid phase extraction (LLE or SPE))
Determination of the nominal mass per direct injection
Analysis of the intact mass by direct injection
*The client understands and agrees that the services of the platform should not be used to make a clinical diagnosis as part of standard patient care. 

 

About this page
Updated on 10/8/2021
Created on 10/8/2021
Alert or send a suggestion
 

Every dollar counts!

Thank you for your generosity.

It's people like you that allow us to accelerate research and heal more children better every year and, as such, offer among the best healthcare in the world.

It's also possible to give by mail or by calling toll-free

1-888-235-DONS (3667)

Contact Us

514 345-4931

Légal

© 2006-2014 CHU Sainte-Justine.
All rights reserved.
Terms of Use, Confidentiality, Security

Avertissement

Les informations contenues dans le site « CHU Sainte-Justine » ne doivent pas être utilisées comme un substitut aux conseils d’un médecin dûment qualifié et autorisé ou d’un autre professionnel de la santé. Les informations fournies ici le sont à des fins exclusivement éducatives et informatives.

Consultez votre médecin si vous croyez être malade ou composez le 911 pour toute urgence médicale.

CHU Sainte-Justine